INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• A New Take On The Evolving Role Of AI In Clinical Trials

  Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.

• From 3 Meetings To 1: Remove Bottlenecks With AI-Enabled eCOA

  Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.

• Leveraging AI In HEOR: Innovation In Evidence And Outcomes

  Stay at the forefront of digital innovation in healthcare and understand how artificial intelligence is revolutionizing Health Economics and Outcomes Research (HEOR) in this insightful video.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• Building A Clinical Research AI Governance Framework

  6/15/2026

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• Improving Clinical Trial Performance Through Central eSource

  10/23/2025

  See how a top five pharmaceutical company leveraged our esource platform to enhance site performance, improve data consistency, and enable remote monitoring.

• Can Your Clinical Trial Partners Protect Data At Global Scale?

  6/19/2026

  Clinical trial data crosses borders, systems, and sponsors daily. This presentation unpacks what responsible privacy looks like on a global scale and how privacy by design keeps studies moving safely.

• A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data

  2/25/2025

  Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

• Different Stakeholder Perspectives On Navigating DHT Guidance

  11/21/2024

  In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.